Wednesday, September 20, 2017 - 13:13
Sopharma AD notifies that from 18 September 2017 up to and including 19 September 2017 Sopharma AD acquired 12 927 shares from the capital of Unipharm AD as a result of filed requests under the provisions of art. 157b from the LOPS.
The term under art. 157b expired on 19 September 2017.